Fig 3. Harris Hematoxylin and Eosin stained representative sections near implants site taken on Post-Operative Day 12 (magnification 10x, black scale bars = 100 μm).

(A) Saratin/Ilomostat; (B) Saratin/Bevacizumab/Ilomostat; (C) BSS; (D) MMC (all representative, come from areas of roughly the same location in relation to tube placement).